Cell-free protein expression using rolling circle amplification product
Methods for in vitro transcription and translation from an RCA product are provided. The methods comprise providing a double-stranded RCA product, wherein the double-stranded RCA product consists essentially of tandem repeats of a minimalistic expression sequence. The methods further comprise expressing a protein from the double-stranded RCA product in a cell-free expression system.
1. A method for in vitro transcription comprising:
generating a ribonucleic acid (RNA) in a cell-free transcription reaction from a double-stranded rolling circle amplification (RCA) product comprising tandem repeats of a minimalistic deoxyribonucleic acid (DNA) sequence of interest,
wherein the minimalistic DNA sequence of interest comprises a promoter sequence and an RNA coding region,
wherein the DNA sequence of interest is devoid of a transcription termination sequence, and
wherein the double-stranded RCA product is devoid of any extraneous sequences that are required for propagation of a plasmid in a host cell.
2. The method of claim 1 , wherein the promoter sequence is located upstream of the RNA coding region in the DNA sequence of interest.
3. The method of claim 1 , wherein the DNA sequence of interest further comprises an insulator sequence.
4. The method of claim 1 , wherein the DNA sequence of interest further comprises a purification tag sequence.
5. The method of claim 1 , wherein the DNA sequence of interest is a codon-optimized sequence for enhancing RNA stability.
6. The method of claim 1 , wherein the generated RNA comprises tandem repeats of cistronic RNA species, wherein each cistronic RNA species comprises an RNA sequence coded by the DNA sequence of interest.
7. The method of claim 1 , wherein the double-stranded RCA product comprises a thioated nucleotide.
8. The method of claim 1 , wherein the cell-free transcription reaction is performed using a prokaryotic cell extract, a eukaryotic cell extract, or a combination thereof.
9. A method for in vitro transcription, comprising:
generating a double-stranded rolling circle amplification (RCA) product via rolling circle amplification of a deoxyribonucleic acid (DNA) mini-circle comprising a minimalistic DNA sequence of interest; and
generating a ribonucleic acid (RNA) in a cell-free transcription reaction from the double-stranded RCA product,
wherein the minimalistic DNA sequence of interest comprises a promoter sequence and an RNA coding region,
wherein the DNA sequence of interest is devoid of a transcription termination sequence, and
wherein the DNA mini-circle is devoid of any extraneous sequences that are required for propagation of a plasmid in a host cell.
10. The method of claim 9 , wherein the double-stranded RCA product is used in the cell-free transcription reaction without any further processing.
11. The method of claim 9 , wherein the double-stranded RCA product comprises a thioated nucleotide.
12. The method of claim 9 , wherein the cell-free transcription reaction is performed using a prokaryotic cell extract, a eukaryotic cell extract, or a combination thereof.
13. The method of claim 9 , wherein the DNA sequence of interest further comprises an insulator sequence.
14. The method of claim 9 , wherein the DNA sequence of interest further comprises a purification tag sequence.
15. The method of claim 9 , wherein the DNA sequence of interest is a codon-optimized sequence for enhancing RNA stability.
16. The method of claim 9 , wherein the generated RNA comprises tandem repeats of cistronic RNA species, wherein each cistronic RNA species comprises an RNA sequence coded by the DNA sequence of interest.
17. The method of claim 9 , wherein the rolling circle amplification is performed using a final concentration of deoxyribonucleoside triphosphates (dNTPs) in a range of 10 μM to 10 mM.
18. The method of claim 9 , wherein the rolling circle amplification is performed using a random primer mixture comprising a nucleotide analogue, and wherein the nucleotide analogue is an inosine, a Locked Nucleic Acid (LNA) nucleotide, a Peptide Nucleic Acid (PNA) nucleotide, a thioated nucleotide, 2-amino-deoxyadenosine, 2-thio-deoxythymidine, a polycation nucleotide, or a Zip Nucleic Acid (ZNA) polycation modified nucleotide.
19. The method of claim 18 , wherein the random primer mixture has a sequence +N+N(atN)(atN)(atN)*N.